OTCMKTS:BAYRY - Bayer Stock Price, Price Target & More

Sign in or create an account to add this stock to your watchlist.
$29.50 -0.17 (-0.57 %)
(As of 05/25/2018 04:00 PM ET)
Previous Close$29.50
Today's Range$29.08 - $29.50
52-Week Range$27.60 - $35.41
Volume206,160 shs
Average Volume366,737 shs
Market Capitalization$99.93 billion
P/E Ratio15.53
Dividend Yield1.78%
Beta1.18

About Bayer (OTCMKTS:BAYRY)

Bayer logoBayer Aktiengesellschaft operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, Crop Science, and Animal Health segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, and cosmetics in the dermatology, nutritional supplement, analgesic, digestive health, allergy, cold, foot care, and sun protection categories. The Crop Science segment offers crop protection products, seeds, non-agriculture pest control products. The Animal Health segment develops and markets products and solutions for the prevention and treatment of disease in companion and farm animals to vets, farmers, and pet-owners. The company was founded in 1863 and is headquartered in Leverkusen, Germany.

Receive BAYRY News and Ratings via Email

Sign-up to receive the latest news and ratings for BAYRY and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
SymbolOTCMKTS:BAYRY
CUSIPN/A
Phone49-21-4-30-1

Debt

Debt-to-Equity Ratio0.34
Current Ratio2.21
Quick Ratio1.73

Price-To-Earnings

Trailing P/E Ratio15.53
Forward P/E Ratio13.23
P/E Growth2.74

Sales & Book Value

Annual Sales$39.55 billion
Price / Sales2.47
Cash Flow$2.5968 per share
Price / Cash11.36
Book Value$12.60 per share
Price / Book2.34

Profitability

EPS (Most Recent Fiscal Year)$1.90
Net Income$8.29 billion
Net Margins11.96%
Return on Equity19.26%
Return on Assets7.96%

Miscellaneous

Employees115,200
Outstanding Shares3,307,800,000

Bayer (OTCMKTS:BAYRY) Frequently Asked Questions

What is Bayer's stock symbol?

Bayer trades on the OTCMKTS under the ticker symbol "BAYRY."

How often does Bayer pay dividends? What is the dividend yield for Bayer?

Bayer declared an annual dividend on Monday, March 19th. Stockholders of record on Tuesday, May 29th will be paid a dividend of $0.614 per share on Monday, June 11th. The ex-dividend date is Friday, May 25th. View Bayer's Dividend History.

How were Bayer's earnings last quarter?

Bayer (OTCMKTS:BAYRY) released its earnings results on Wednesday, February, 28th. The company reported $0.42 EPS for the quarter, topping the Thomson Reuters' consensus estimate of $0.31 by $0.11. The company had revenue of $10.12 billion for the quarter. Bayer had a net margin of 11.96% and a return on equity of 19.26%. View Bayer's Earnings History.

When is Bayer's next earnings date?

Bayer is scheduled to release their next quarterly earnings announcement on Thursday, July, 26th 2018. View Earnings Estimates for Bayer.

Who are some of Bayer's key competitors?

Who are Bayer's key executives?

Bayer's management team includes the folowing people:
  • Mr. Werner Baumann, Chairman of Management & CEO (Age 56)
  • Mr. Johannes M. Dietsch, Head of Fin. Dept, CFO - Asia/Pacific Region & Member of Management Board (Age 56)
  • Mr. Liam Condon, CEO of Bayer Cropscience & Member of Management Board (Age 50)
  • Dr. Kemal Malik, Head of Innovation & Member of Management Board (Age 56)
  • Dr. Hartmut Klusik, Head of HR, Technology & Sustainability, Labor Director and Member of Management Board (Age 62)

Has Bayer been receiving favorable news coverage?

News articles about BAYRY stock have been trending somewhat positive on Friday, according to Accern Sentiment. Accern rates the sentiment of press coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Bayer earned a media sentiment score of 0.12 on Accern's scale. They also gave press coverage about the company an impact score of 46.66 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the next few days.

How do I buy shares of Bayer?

Shares of BAYRY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Bayer's stock price today?

One share of BAYRY stock can currently be purchased for approximately $29.50.

How big of a company is Bayer?

Bayer has a market capitalization of $99.93 billion and generates $39.55 billion in revenue each year. The company earns $8.29 billion in net income (profit) each year or $1.90 on an earnings per share basis. Bayer employs 115,200 workers across the globe.

How can I contact Bayer?

Bayer's mailing address is Kaiser-Wilhelm-Allee 1, Leverkusen 2M, 51368. The company can be reached via phone at 49-21-4-30-1 or via email at [email protected]


MarketBeat Community Rating for Bayer (BAYRY)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  206 (Vote Outperform)
Underperform Votes:  256 (Vote Underperform)
Total Votes:  462
MarketBeat's community ratings are surveys of what our community members think about Bayer and other stocks. Vote "Outperform" if you believe BAYRY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BAYRY will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Bayer (OTCMKTS:BAYRY) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
3 Wall Street analysts have issued ratings and price targets for Bayer in the last 12 months. There are currently 1 hold rating and 2 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyBuy
Consensus Rating Score: 2.672.502.672.83
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
2 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: N/AN/AN/AN/A
Price Target Upside: N/AN/AN/AN/A

Bayer (OTCMKTS:BAYRY) Consensus Price Target History

Price Target History for Bayer (OTCMKTS:BAYRY)

Bayer (OTCMKTS:BAYRY) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetDetails
5/17/2018DZ BankReiterated RatingBuyView Rating Details
9/25/2017BNP ParibasUpgradeNeutral ➝ OutperformView Rating Details
7/3/2017Berenberg BankDowngradeBuy ➝ HoldView Rating Details
2/24/2017Sanford C. BernsteinReiterated RatingOutperformView Rating Details
1/4/2017JPMorgan Chase & Co.UpgradeNeutral ➝ OverweightView Rating Details
12/19/2016Jefferies GroupUpgradeHold ➝ BuyView Rating Details
12/7/2016UBSUpgradeNeutral ➝ BuyView Rating Details
9/14/2016Goldman Sachs GroupReiterated RatingBuyView Rating Details
8/25/2016CitigroupUpgradeNeutral ➝ BuyView Rating Details
5/25/2016CommerzbankUpgradeHold ➝ BuyView Rating Details
5/25/2016Deutsche BankReiterated RatingBuyView Rating Details
(Data available from 5/25/2016 forward)

Earnings

Bayer (OTCMKTS:BAYRY) Earnings History and Estimates Chart

Earnings by Quarter for Bayer (OTCMKTS:BAYRY)

Bayer (OTCMKTS:BAYRY) Earnings Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20181$0.65$0.65$0.65

Bayer (OTCMKTS BAYRY) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/26/2018        
2/28/2018Q4 2017$0.31$0.42$10.1235 billionViewN/AView Earnings Details
10/26/2017Q3 2017$0.29$0.43$9.7001 billionViewN/AView Earnings Details
7/27/20176/30/2017$1.87$1.99$14.4512 billion$13.4097 billionViewN/AView Earnings Details
4/27/20173/31/2017$2.40$2.80$13.6505 billion$14.1120 billionViewN/AView Earnings Details
10/26/2016Q3$1.80$1.93$12.3939 billion$12.5666 billionViewListenView Earnings Details
7/27/2016Q2 2016$0.55$0.59$13.4544 billion$13.3641 billionViewN/AView Earnings Details
4/26/2016Q1 2016$0.62$0.65$13.5773 billion$13.1716 billionViewN/AView Earnings Details
2/25/2016Q4 2015$0.33$0.29$12.2810 billion$12.3988 billionViewN/AView Earnings Details
10/29/2015Q3$1.65$1.88$12.7909 billion$12.2765 billionViewListenView Earnings Details
7/29/2015Q2 2015$0.51$0.55$13.5767 billion$13.3752 billionViewN/AView Earnings Details
4/30/2015Q1 2015$2.35$2.33$12.8097 billion$13.4515 billionViewN/AView Earnings Details
2/26/2015Q4 2014$1.35$12.5311 billionViewN/AView Earnings Details
10/30/2014Q3 2014$0.43$12.9651 billionViewN/AView Earnings Details
7/30/2014Q2 2014$2.05$14.0189 billionViewN/AView Earnings Details
4/24/2014Q1 2014$2.47$2.35$14.6653 billion$14.5944 billionViewN/AView Earnings Details
2/28/2014Q4 2013$0.38$13.5471 billionViewN/AView Earnings Details
10/31/2013Q3 2013$0.42$12.7741 billionViewN/AView Earnings Details
7/31/2013Q2 2013$0.51$13.7399 billionViewN/AView Earnings Details
4/25/2013Q1 2013$0.55$13.3473 billionViewN/AView Earnings Details
2/28/2013Q4 2012$0.37$0.32ViewN/AView Earnings Details
10/30/2012Q3 2012$0.38ViewN/AView Earnings Details
7/31/2012Q2 2012$0.47ViewN/AView Earnings Details
4/26/2012Q1 2012$0.56ViewN/AView Earnings Details
2/28/2012Q4 2011$0.32$0.33ViewN/AView Earnings Details
10/26/2011Q3 2011$0.34$0.39ViewN/AView Earnings Details
7/28/2011Q2 2011$0.38$0.47ViewN/AView Earnings Details
4/27/2011Q1 2011$0.32$0.28ViewN/AView Earnings Details
2/28/2011Q4 2010$0.33ViewN/AView Earnings Details
11/1/2010Q3 2010$0.11ViewN/AView Earnings Details
7/30/2010Q2 2010$0.33$0.20ViewN/AView Earnings Details
4/29/2010Q1 2010$0.40ViewN/AView Earnings Details
11/23/2009Q3 2009$0.21$0.11ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Dividends

Bayer (OTCMKTS:BAYRY) Dividend Information

Bayer pays an annual dividend of $0.54 per share, with a dividend yield of 1.83%. BAYRY's next annual dividend payment will be made on Monday, June 11. Bayer pays out 28.42% of its earnings out as a dividend.
Next Dividend:6/11/2018
Annual Dividend:$0.54
Dividend Yield:1.83%
Payout Ratio(s):28.42% (Trailing 12 Months of Earnings)
24.22% (Based on This Year's Estimates)
22.31% (Based on Next Year's Estimates)
20.79% (Based on Cash Flow)
Dividend Payments by Quarter for Bayer (OTCMKTS:BAYRY)

Bayer (OTCMKTS:BAYRY) Dividend History by Quarter

AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/19/2018Annual$0.61405/25/20185/29/20186/11/2018
6/29/2017Annual$2.15705/1/20175/3/20175/15/2017
(Data available from 1/1/2013 forward)

Insider Trades

Bayer (OTCMKTS BAYRY) Insider Trading and Institutional Ownership History

Institutional Ownership Percentage: 0.82%
Insider Trading History for Bayer (OTCMKTS:BAYRY)

Bayer (OTCMKTS BAYRY) Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
(Data available from 1/1/2013 forward)

Headlines

Bayer (OTCMKTS BAYRY) News Headlines

Source:
DateHeadline
Journal Profile: Owner of Milk + Honey spas ready to grow nationwideJournal Profile: Owner of Milk + Honey spas ready to grow nationwide
www.bizjournals.com - May 25 at 9:03 AM
Bayer cuts Monsanto earnings synergies outlook by $300MBayer cuts Monsanto earnings synergies outlook by $300M
seekingalpha.com - May 25 at 9:03 AM
Market Morning Roundup – Futures Down, Facebook Wants Your SSN, Fed Minutes, Weed-Killing RobotsMarket Morning Roundup – Futures Down, Facebook Wants Your SSN, Fed Minutes, Weed-Killing Robots
finance.yahoo.com - May 23 at 4:52 PM
Bayer Presents Preliminary Insights from Global Patient Survey at World Federation of Hemophilia 2018 World CongressBayer Presents Preliminary Insights from Global Patient Survey at World Federation of Hemophilia 2018 World Congress
www.prnewswire.com - May 23 at 8:56 AM
Covestro to Cut Its Teeth on Small M&A Before Unlocking BillionsCovestro to Cut Its Teeth on Small M&A Before Unlocking Billions
finance.yahoo.com - May 23 at 8:56 AM
Comparing Bayer (BAYRY) & Its PeersComparing Bayer (BAYRY) & Its Peers
www.americanbankingnews.com - May 22 at 7:24 PM
Vanessa Bayer Feared Doing The Porn Stars Skit With Donald Trump On SNLVanessa Bayer Feared Doing The 'Porn Stars' Skit With Donald Trump On 'SNL'
www.huffingtonpost.com - May 22 at 9:01 AM
CCI clears Bayers deal for MonsantoCCI clears Bayer's deal for Monsanto
finance.yahoo.com - May 22 at 9:01 AM
Indian regulator clears Bayers deal for MonsantoIndian regulator clears Bayer's deal for Monsanto
finance.yahoo.com - May 22 at 9:01 AM
Bayer Declares Annual Dividend of $0.61 (BAYRY)Bayer Declares Annual Dividend of $0.61 (BAYRY)
www.americanbankingnews.com - May 20 at 8:00 AM
El futbolista Jérôme Boateng prepara una colección de diseño con /NydenEl futbolista Jérôme Boateng prepara una colección de diseño con /Nyden
www.prnewswire.com - May 17 at 10:30 PM
Le footballeur Jérôme Boateng va dessiner une collection avec /NydenLe footballeur Jérôme Boateng va dessiner une collection avec /Nyden
www.prnewswire.com - May 17 at 8:15 PM
Piłkarz Jérôme Boateng zaprojektuje kolekcję z /NydenPiłkarz Jérôme Boateng zaprojektuje kolekcję z /Nyden
www.prnewswire.com - May 17 at 6:27 PM
Bayer (BAYRY) Rating Reiterated by DZ BankBayer (BAYRY) Rating Reiterated by DZ Bank
www.americanbankingnews.com - May 17 at 4:52 PM
BRIEF-Bayer Cropscience Agreed To Settle A Lawsuit Brought By Calyxt In Delaware Chancery CourtBRIEF-Bayer Cropscience Agreed To Settle A Lawsuit Brought By Calyxt In Delaware Chancery Court
www.reuters.com - May 16 at 9:22 AM
Bayer to Present Pulmonary Hypertension Data at the American Thoracic Society 2018 International ConferenceBayer to Present Pulmonary Hypertension Data at the American Thoracic Society 2018 International Conference
www.prnewswire.com - May 15 at 9:37 AM
Why Bayer Aktiengesellschaft (BAYRY) Might Surprise This Earnings SeasonWhy Bayer Aktiengesellschaft (BAYRY) Might Surprise This Earnings Season
finance.yahoo.com - May 15 at 9:37 AM
Jan Price, National Director of Womens HealthCare and Neurology Medical Science Liaisons Teams at Bayer ...Jan Price, National Director of Women's HealthCare and Neurology Medical Science Liaisons Teams at Bayer ...
www.prnewswire.com - May 11 at 9:54 AM
BRIEF-Bayer Receives Approval For Eylea In ChinaBRIEF-Bayer Receives Approval For Eylea In China
www.reuters.com - May 11 at 9:54 AM
Roches doublet therapy fails to beat Bayers Stivarga in late-stage CRC studyRoche's doublet therapy fails to beat Bayer's Stivarga in late-stage CRC study
seekingalpha.com - May 10 at 7:31 AM
Monsanto CEO to Leave After Sale to BayerMonsanto CEO to Leave After Sale to Bayer
www.wsj.com - May 9 at 9:13 AM
Face of GMOs at Monsanto to Step Down as Bayer Takeover ClosesFace of GMOs at Monsanto to Step Down as Bayer Takeover Closes
www.bloomberg.com - May 8 at 9:07 AM
BRIEF-Monsanto CEO Announces Intent To Leave Co Upon Closing Of Bayer AcquisitionBRIEF-Monsanto CEO Announces Intent To Leave Co Upon Closing Of Bayer Acquisition
www.reuters.com - May 7 at 9:02 AM
Monsanto CEO Hugh Grant to step down after Bayer deal closesMonsanto CEO Hugh Grant to step down after Bayer deal closes
www.theglobeandmail.com - May 7 at 9:02 AM
Monsanto CEO Hugh Grant says he will step down once the Bayer deal closesMonsanto CEO Hugh Grant says he will step down once the Bayer deal closes
finance.yahoo.com - May 7 at 9:02 AM
Monsanto says CEO Hugh Grant will step down after Bayer deal closesMonsanto says CEO Hugh Grant will step down after Bayer deal closes
finance.yahoo.com - May 7 at 9:02 AM
Bayer (BAYRY) Cut to "Sell" at ValuEngineBayer (BAYRY) Cut to "Sell" at ValuEngine
www.americanbankingnews.com - May 5 at 2:27 PM
Bayers (BAYZF) CEO Werner Baumann on Q1 2018 Results - Earnings Call TranscriptBayer's (BAYZF) CEO Werner Baumann on Q1 2018 Results - Earnings Call Transcript
seekingalpha.com - May 4 at 9:05 AM
BASF: No key savings from Bayer agriculture assetsBASF: No key savings from Bayer agriculture assets
www.marketwatch.com - May 4 at 9:05 AM
Bayer sells further Covestro stake for 2.2 billion eurosBayer sells further Covestro stake for 2.2 billion euros
finance.yahoo.com - May 4 at 9:05 AM
Bayer A.G. beats by €0.20, misses on revenueBayer A.G. beats by €0.20, misses on revenue
seekingalpha.com - May 3 at 6:31 AM
Bayer (BAYRY) Upgraded by Zacks Investment Research to HoldBayer (BAYRY) Upgraded by Zacks Investment Research to Hold
www.americanbankingnews.com - May 2 at 12:25 PM
BRIEF-Cadila Healthcare Gets Exit Price For Sale Of Shares To Bayer (South East Asia)BRIEF-Cadila Healthcare Gets Exit Price For Sale Of Shares To Bayer (South East Asia)
www.reuters.com - May 2 at 9:08 AM
What's in the Offing for Regeneron (REGN) in Q1 Earnings?What's in the Offing for Regeneron (REGN) in Q1 Earnings?
finance.yahoo.com - May 1 at 9:11 AM
EU approves BASF deal to buy Bayer assetsEU approves BASF deal to buy Bayer assets
www.marketwatch.com - April 30 at 9:18 AM
BRIEF-Cadila Healthcare To Sell 12.5 Mln Shares Of JV To Bayer (South East Asia)BRIEF-Cadila Healthcare To Sell 12.5 Mln Shares Of JV To Bayer (South East Asia)
www.reuters.com - April 27 at 9:38 AM
Bayer, Monsanto deal could be approved in US by end of May: ReportBayer, Monsanto deal could be approved in US by end of May: Report
www.bizjournals.com - April 26 at 8:59 AM
Bayer, Monsanto deal on track for U.S. approval by end of May - sourceBayer, Monsanto deal on track for U.S. approval by end of May - source
finance.yahoo.com - April 26 at 8:59 AM
Bayer (BAYRY) Lowered to "Hold" at Zacks Investment ResearchBayer (BAYRY) Lowered to "Hold" at Zacks Investment Research
www.americanbankingnews.com - April 18 at 7:30 PM
BRIEF-Evotec Says Endometriosis Programme With Bayer Moves To Phase I DevelopmentBRIEF-Evotec Says Endometriosis Programme With Bayer Moves To Phase I Development
www.reuters.com - April 18 at 9:12 AM
Preclinical Data Presented by Bayer at AACR Highlights BAY 1905254, Formerly the CGEN-15001T Program, Efficacy ...Preclinical Data Presented by Bayer at AACR Highlights BAY 1905254, Formerly the CGEN-15001T Program, Efficacy ...
www.prnewswire.com - April 17 at 9:31 AM
Bayer to sell $3.7 bln of new shares to TemasekBayer to sell $3.7 bln of new shares to Temasek
www.marketwatch.com - April 17 at 9:31 AM
The US Approves Bayer And Monsantos MergerThe US Approves Bayer And Monsanto's Merger
seekingalpha.com - April 17 at 9:31 AM
Professional Life Coach Mike Bayer Joins Daytime Televisions #1 Rated Talk Show Dr. Phil as Coach MikeProfessional Life Coach Mike Bayer Joins Daytime Television's #1 Rated Talk Show Dr. Phil as 'Coach Mike'
www.prnewswire.com - April 16 at 4:39 PM
Easton Pharmaceuticals Announces BAYER Agreement UpdateEaston Pharmaceuticals Announces BAYER Agreement Update
globenewswire.com - April 16 at 9:03 AM
BRIEF-Easton Pharmaceuticals Says Agreement with Bayer and Its Unit Has ClosedBRIEF-Easton Pharmaceuticals Says Agreement with Bayer and Its Unit Has Closed
www.reuters.com - April 16 at 9:03 AM
BASF to Crank Up R&D `Two Gears With Bayer Seeds, Next CEO SaysBASF to Crank Up R&D `Two Gears' With Bayer Seeds, Next CEO Says
www.bloomberg.com - April 16 at 9:03 AM
Brokers Set Expectations for Bayers Q1 2018 Earnings (BAYRY)Brokers Set Expectations for Bayer's Q1 2018 Earnings (BAYRY)
www.americanbankingnews.com - April 16 at 1:44 AM
Bayer to sell digital farming business to win approval for Monsanto dealBayer to sell digital farming business to win approval for Monsanto deal
finance.yahoo.com - April 11 at 9:45 AM
European shares led higher by Bayer, luxury stocksEuropean shares led higher by Bayer, luxury stocks
www.nasdaq.com - April 10 at 9:33 AM

SEC Filings

Bayer (OTCMKTS:BAYRY) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Bayer (OTCMKTS:BAYRY) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Bayer (OTCMKTS BAYRY) Stock Chart for Friday, May, 25, 2018

Loading chart…

This page was last updated on 5/25/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.